Clinical Supply Regulatory Articles

  1. Annex 22 Is Not A Brake On AI. It Is The Framework Clinical Supply Has Been Waiting For 7/24/2026

    EU GMP Annex 22 provides a practical framework for adopting AI in clinical supply, helping teams validate forecasting, planning, and decision support with confidence.

  2. Rhogam's Unconventional History And Why There Is No True Synthetic Replacement (Part 2 of 3) 7/17/2026

    Rhogam transformed Rh disease prevention, but its plasma-derived, polyclonal biology has resisted decades of synthetic anti-D replacement efforts.

  3. First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members 7/16/2026

    Clinical Supply Leader unveils its first Editorial Advisory Board, featuring leaders across clinical supply, quality, regulatory affairs, technology, and strategy.

  4. Export Control Risks Hidden In Clinical Supply Workflows 6/26/2026

    Export control risks often hide in data sharing, technology transfers, and partner access. Learn where compliance gaps emerge before regulators do.

  5. The Post-American Supply Chain: Navigating The New Multipolar Clinical Landscape 6/25/2026

    Think global trial supply is just FDA compliance? Customs rules, local sourcing mandates, climate extremes, and regional regulations say otherwise.

  6. Global Labeling And Packaging In Complex Supply Environments 6/18/2026

    Global labeling and packaging are central to clinical supply performance, shaping regulatory compliance, serialization, and design choices that affect patient safety now.

  7. What Clinical Trial Supply Teams Actually Need From CQV Before Batch Release 6/15/2026

    Batch release delays rarely start in QA. Learn how CQV, digital integrity, risk-based validation, and global compliance keep clinical supplies moving.

  8. How The Iran Conflict Threatens Global Clinical Supply Chains 6/9/2026

    Geopolitical disruption is exposing hidden weaknesses in clinical supply networks, forcing sponsors to rethink inventory, depots, comparators, and trial continuity.

  9. Unlocking The Value Of Real-World Data In Global Clinical Trials 6/5/2026

    Global real-world data can accelerate trials or quietly distort forecasts, inventory strategy, and regulatory decisions across clinical supply operations.

  10. Want Faster FDA Release For Pharmaceutical Imports? Here's How. 5/28/2026

    FDA import delays can derail clinical trials. Learn the exact data, documentation, and compliance steps that speed pharmaceutical release.